Neurobehavioral radiation mitigation to standard brain cancer therapy regimens by Mn(III)n-butoxyethylpyridylporphyrin-based redox modifier-Reference-Cited by-同舟云学术

Neurobehavioral radiation mitigation to standard brain cancer therapy regimens by Mn(III)n-butoxyethylpyridylporphyrin-based redox modifier

Published:2016-05-25 Issue:5 Volume:57 Page:372-381
ISSN:0893-6692
Container-title:Environmental and Molecular Mutagenesis
language:en
Short-container-title:Environ. Mol. Mutagen.

Author:

Weitzel Douglas H.¹,Tovmasyan Artak¹,Ashcraft Kathleen A.¹,Boico Alina¹,Birer Samuel R.¹,Roy Choudhury Kingshuk²,Herndon James²,Rodriguiz Ramona M.³⁴,Wetsel William C.³⁴⁵⁶,Peters Katherine B.⁷,Spasojevic Ivan⁸,Batinic-Haberle Ines¹,Dewhirst Mark W.¹⁹

Affiliation:

1. Department of Radiation Oncology; Duke University Medical Center; Durham North Carolina

2. Department of Biostatistics and Bioinformatics; Duke University Medical Center; Durham North Carolina

3. Department of Psychiatry and Behavioral Sciences; Duke University Medical Center; Durham North Carolina

4. Department of Mouse Behavioral and Neuroendocrine Analysis Core Facility; Duke University Medical Center; Durham North Carolina

5. Department of Cell Biology; Duke University Medical Center; Durham North Carolina

6. Department of Neurobiology; Duke University Medical Center; Durham North Carolina

7. Medicine and Duke Cancer Institute, Duke University Medical Center; Durham North Carolina

8. PK/PD BioAnalytical DCI Shared Resource; Duke University Medical Center; Durham North Carolina

9. Preston Robert Tisch Brain Tumor Center; Duke University Medical Center; Durham North Carolina

Funder

Pediatric Brain Tumor Foundation

Preston Robert Tisch Brain Tumor Center at Duke

North Carolina Biotechnology Center Grant

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Genetics(clinical),Epidemiology

Reference43 articles.

1. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum;Archambeau;Redox Biol,2013

2. Novel manganese-porphyrin superoxide dismutase-mimetic widens the therapeutic margin in a preclinical head and neck cancer model;Ashcraft;Int J Radiat Oncol Biol Phys,2015

3. Treatment of radiation-induced cognitive decline;Attia;Curr Treat Options Oncol,2014

4. Superoxide dismutase mimics and other redox-active therapeutics

5. Mechanistic considerations of the therapeutic effects of Mn porphyrins, commonly regarded as SOD mimics, in anticancer therapy: Lessons from brain and lymphoma studies;Batinic-Haberle;Free Radic Biol Med,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sympathoinhibition and vasodilation contribute to the acute hypotensive response of the superoxide dismutase mimic, MnTnBuOE-2-PyP5+, in hypertensive animals;Advances in Redox Research;2021-12

2. H2O2-Driven Anticancer Activity of Mn Porphyrins and the Underlying Molecular Pathways;Oxidative Medicine and Cellular Longevity;2021-03-15

3. Metalloporphyrins in Medicine: From History to Recent Trends;ACS Applied Bio Materials;2020-11-06

4. The novel SOD mimetic GC4419 increases cancer cell killing with sensitization to ionizing radiation while protecting normal cells;Free Radical Biology and Medicine;2020-11

5. Nanoformulation of the superoxide dismutase mimic, MnTnBuOE-2-PyP5+, prevents its acute hypotensive response;Redox Biology;2020-09